Literature DB >> 35264763

Could drugs prevent Alzheimer's? These trials aim to find out.

Alison Abbott.   

Abstract

Entities:  

Keywords:  Alzheimer's disease; Drug discovery; Neurodegeneration

Mesh:

Year:  2022        PMID: 35264763     DOI: 10.1038/d41586-022-00651-0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  8 in total

1.  Evidence of amyloid beta-protein immunoreactive early plaque lesions in Down's syndrome brains.

Authors:  S Ikeda; N Yanagisawa; D Allsop; G G Glenner
Journal:  Lab Invest       Date:  1989-07       Impact factor: 5.662

Review 2.  Impact of multiple pathologies on the threshold for clinically overt dementia.

Authors:  Alifiya Kapasi; Charles DeCarli; Julie A Schneider
Journal:  Acta Neuropathol       Date:  2017-05-09       Impact factor: 17.088

3.  Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease.

Authors:  A Goate; M C Chartier-Harlin; M Mullan; J Brown; F Crawford; L Fidani; L Giuffra; A Haynes; N Irving; L James
Journal:  Nature       Date:  1991-02-21       Impact factor: 49.962

4.  Association Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal Persons.

Authors:  Michael C Donohue; Reisa A Sperling; Ronald Petersen; Chung-Kai Sun; Michael W Weiner; Paul S Aisen
Journal:  JAMA       Date:  2017-06-13       Impact factor: 56.272

5.  Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein.

Authors:  G G Glenner; C W Wong
Journal:  Biochem Biophys Res Commun       Date:  1984-08-16       Impact factor: 3.575

6.  A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease.

Authors:  Stephen Salloway; Martin Farlow; Eric McDade; David B Clifford; Guoqiao Wang; Jorge J Llibre-Guerra; Janice M Hitchcock; Susan L Mills; Anna M Santacruz; Andrew J Aschenbrenner; Jason Hassenstab; Tammie L S Benzinger; Brian A Gordon; Anne M Fagan; Kelley A Coalier; Carlos Cruchaga; Alison A Goate; Richard J Perrin; Chengjie Xiong; Yan Li; John C Morris; B Joy Snider; Catherine Mummery; G Mustafa Surti; Didier Hannequin; David Wallon; Sarah B Berman; James J Lah; Ivonne Z Jimenez-Velazquez; Erik D Roberson; Christopher H van Dyck; Lawrence S Honig; Raquel Sánchez-Valle; William S Brooks; Serge Gauthier; Douglas R Galasko; Colin L Masters; Jared R Brosch; Ging-Yuek Robin Hsiung; Suman Jayadev; Maité Formaglio; Mario Masellis; Roger Clarnette; Jérémie Pariente; Bruno Dubois; Florence Pasquier; Clifford R Jack; Robert Koeppe; Peter J Snyder; Paul S Aisen; Ronald G Thomas; Scott M Berry; Barbara A Wendelberger; Scott W Andersen; Karen C Holdridge; Mark A Mintun; Roy Yaari; John R Sims; Monika Baudler; Paul Delmar; Rachelle S Doody; Paulo Fontoura; Caroline Giacobino; Geoffrey A Kerchner; Randall J Bateman
Journal:  Nat Med       Date:  2021-06-21       Impact factor: 87.241

7.  Acute targeting of pre-amyloid seeds in transgenic mice reduces Alzheimer-like pathology later in life.

Authors:  Ruth E Uhlmann; Christine Rother; Jay Rasmussen; Juliane Schelle; Carina Bergmann; Emily M Ullrich Gavilanes; Sarah K Fritschi; Anika Buehler; Frank Baumann; Angelos Skodras; Rawaa Al-Shaana; Natalie Beschorner; Lan Ye; Stephan A Kaeser; Ulrike Obermüller; Søren Christensen; Fredrik Kartberg; Jeffrey B Stavenhagen; Jens-Ulrich Rahfeld; Holger Cynis; Fang Qian; Paul H Weinreb; Thierry Bussiere; Lary C Walker; Matthias Staufenbiel; Mathias Jucker
Journal:  Nat Neurosci       Date:  2020-11-16       Impact factor: 28.771

8.  Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study.

Authors:  Brian A Gordon; Tyler M Blazey; Yi Su; Amrita Hari-Raj; Aylin Dincer; Shaney Flores; Jon Christensen; Eric McDade; Guoqiao Wang; Chengjie Xiong; Nigel J Cairns; Jason Hassenstab; Daniel S Marcus; Anne M Fagan; Clifford R Jack; Russ C Hornbeck; Katrina L Paumier; Beau M Ances; Sarah B Berman; Adam M Brickman; David M Cash; Jasmeer P Chhatwal; Stephen Correia; Stefan Förster; Nick C Fox; Neill R Graff-Radford; Christian la Fougère; Johannes Levin; Colin L Masters; Martin N Rossor; Stephen Salloway; Andrew J Saykin; Peter R Schofield; Paul M Thompson; Michael M Weiner; David M Holtzman; Marcus E Raichle; John C Morris; Randall J Bateman; Tammie L S Benzinger
Journal:  Lancet Neurol       Date:  2018-02-01       Impact factor: 44.182

  8 in total
  3 in total

Review 1.  Aβ and Tau Regulate Microglia Metabolism via Exosomes in Alzheimer's Disease.

Authors:  Yuanxin Zhao; Buhan Liu; Jian Wang; Long Xu; Sihang Yu; Jiaying Fu; Xiaoyu Yan; Jing Su
Journal:  Biomedicines       Date:  2022-07-27

2.  MicroRNA-22-3p ameliorates Alzheimer's disease by targeting SOX9 through the NF-κB signaling pathway in the hippocampus.

Authors:  Pengcheng Xia; Jing Chen; Yingchao Liu; Xiaolin Cui; Cuicui Wang; Shuai Zong; Le Wang; Zhiming Lu
Journal:  J Neuroinflammation       Date:  2022-07-12       Impact factor: 9.587

Review 3.  Direct Oral Anticoagulants (DOACs) for Therapeutic Targeting of Thrombin, a Key Mediator of Cerebrovascular and Neuronal Dysfunction in Alzheimer's Disease.

Authors:  Klaus Grossmann
Journal:  Biomedicines       Date:  2022-08-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.